GI Innovation, Inc. (KOSDAQ:358570)
15,760
-630 (-3.84%)
Apr 28, 2026, 3:30 PM KST
GI Innovation Revenue
In the year 2025, GI Innovation had annual revenue of 5.84B KRW with 23,943.39% growth. GI Innovation had revenue of 5.50B in the quarter ending December 31, 2025.
Revenue
5.84B
Revenue Growth
+23,943.39%
P/S Ratio
173.41
Revenue / Employee
n/a
Employees
n/a
Market Cap
1,012.38B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MEDIPOST | 73.66B |
| Onconic Therapeutics | 53.39B |
| Pharmicell | 23.94B |
| Medy-Tox | 247.29B |
| GC Corp. | 2,451.48B |
| Chabiotech | 1,268.25B |
| Orum Therapeutics | 23.56M |
| SillaJen | 9.23B |